Walvax Biotechnology Co., Ltd. (SHE: 300142)

Walvax Biotechnology Revenue

Walvax Biotechnology had revenue of 708.00M CNY in the quarter ending September 30, 2024, a decrease of -28.51%. This brings the company's revenue in the last twelve months to 3.10B, down -31.76% year-over-year. In the year 2023, Walvax Biotechnology had annual revenue of 4.11B, down -19.12%.

• Revenue (ttm): 3.10B
• Revenue Growth: -31.76%
• P/S Ratio: 8.05
• Revenue / Employee: 1.30M
• Employees: 2,388
• Market Cap: 24.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.11B	-972.67M	-19.12%
Jan 1, 2023	5.09B	1.62B	46.89%
Jan 1, 2022	3.46B	523.81M	17.82%
Dec 31, 2020	2.94B	1.82B	162.13%
Dec 31, 2019	1.12B	246.90M	28.24%